For myeloid malignancies, CHEK2 status was also significant on multivariate analysis (OR 2.34, 95% CI 1.31–3.82, P = 0.002) (Supplemental Fig. 4B). The gene discussed is CHEK2; the disease is myeloid neoplasm.